These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 10023909)
1. Further clues emerge for strategies to attack HIV. McCarthy M Lancet; 1999 Jan; 353(9147):125. PubMed ID: 10023909 [No Abstract] [Full Text] [Related]
2. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Westendorp MO; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin KM; Krammer PH Nature; 1995 Jun; 375(6531):497-500. PubMed ID: 7539892 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients. Rossi C; Balboni PG; Betti M; Marconi PC; Bozzini R; Grossi MP; Barbanti-Brodano G; Caputo A Gene Ther; 1997 Nov; 4(11):1261-9. PubMed ID: 9425451 [TBL] [Abstract][Full Text] [Related]
4. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis. Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948 [TBL] [Abstract][Full Text] [Related]
5. Unraveling the strands of HIV's web. Pantaleo G Nat Med; 1999 Jan; 5(1):27-8. PubMed ID: 9883835 [No Abstract] [Full Text] [Related]
6. Cellular and molecular interactions in HIV infections: a review. Tumbo-Oeri AG; Omwandho CA East Afr Med J; 2002 May; 79(5):249-53. PubMed ID: 12638808 [TBL] [Abstract][Full Text] [Related]
7. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965 [TBL] [Abstract][Full Text] [Related]
8. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells. Faller E; Kakal J; Kumar R; Macpherson P Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839 [TBL] [Abstract][Full Text] [Related]
9. Biochemical mechanisms of HIV induced T cell apoptosis. Selliah N; Finkel TH Cell Death Differ; 2001 Feb; 8(2):127-36. PubMed ID: 11313714 [No Abstract] [Full Text] [Related]
10. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption. de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085 [TBL] [Abstract][Full Text] [Related]
11. HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells. Franzese O; Comandini A; Adamo R; Sgadari C; Ensoli B; Bonmassar E Cell Death Differ; 2004 Jul; 11(7):782-4. PubMed ID: 15017382 [No Abstract] [Full Text] [Related]
12. Antitat gene therapy: a candidate for late-stage AIDS patients. Lisziewicz J; Sun D; Lisziewicz A; Gallo RC Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253 [TBL] [Abstract][Full Text] [Related]
13. The tat gene and protein of the human immunodeficiency virus type 1. Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763 [No Abstract] [Full Text] [Related]
14. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351 [TBL] [Abstract][Full Text] [Related]
15. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children. Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468 [TBL] [Abstract][Full Text] [Related]
16. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. Maggiorella MT; Baroncelli S; Michelini Z; Fanales-Belasio E; Moretti S; Sernicola L; Cara A; Negri DR; Buttò S; Fiorelli V; Tripiciano A; Scoglio A; Caputo A; Borsetti A; Ridolfi B; Bona R; ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Ciccozzi M; Heeney J; Titti F; Cafaro A; Ensoli B Vaccine; 2004 Sep; 22(25-26):3258-69. PubMed ID: 15308348 [TBL] [Abstract][Full Text] [Related]
17. A mathematical model and CD4+ lymphocyte dynamics in HIV infection. Hraba T; Dolezal J Emerg Infect Dis; 1996; 2(4):299-305. PubMed ID: 8969246 [TBL] [Abstract][Full Text] [Related]
18. Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects. De Paoli P Clin Diagn Lab Immunol; 2001 Jul; 8(4):671-7. PubMed ID: 11427409 [No Abstract] [Full Text] [Related]